Bocconia frutescens
Bocconia frutescens · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Bocconia frutescens is a versatile botanical species widely recognized for its diverse pharmacological potential. Researchers have focused on its leaves and bark to develop various crude methanolic, aqueous, and general extracts. These preparations demonstrate significant biological activities, including acting as 12-lipoxygenase and 5-lipoxygenase inhibitors, as well as aldose-reductase inhibitors. Such properties suggest its utility in addressing conditions like gastrointestinal disorders, cough, trichomoniasis, and infections caused by Fasciola hepatica. However, it is important to note that the plant also exhibits abortifacient properties.
- Synonyms
- Bocconia Frutescens Var. Cernua · Bocconia Frutescens Subvar. Glaucescens · 4 more
- Common names
- Not available
- Family
- Papaveraceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Bocconia frutescens is a versatile plant known by a wide array of regional and common names. It is frequently referred to as Bois codine or Celandine in various botanical circles. In different cultural contexts, it is also recognized by the names Chichálítö and Enguambo, particularly within the Región del Bajío. Furthermore, the plant is widely identified as Gordolobo in certain traditional practices. This diversity of nomenclature highlights the plant's significant presence across various linguistic and geographic landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Bocconia frutescens is a complex species that is often identified through various botanical synonyms. Within its taxonomic history, several forms and varieties have been documented, such as Bocconia frutescens f. glaucescens and Bocconia frutescens f. subtomentosa. Researchers have also classified distinct groupings including Bocconia frutescens subvar. glaucescens and Bocconia frutescens var. cernua. Additionally, the name Bocconia frutescens var. subtomentosa appears in scientific literature to describe specific morphological traits. Understanding these overlapping relationships is essential for accurate identification and study of the plant.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Bocconia frutescens is a remarkable specimen belonging to the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It further belongs to the order Ranunculales, showcasing its evolutionary lineage. The species is a distinguished member of the genus Bocconia, which defines its unique morphological traits. Finally, it is nested within the Papaveraceae family, linking it to a diverse group of flowering plants.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Papaveraceae |
| Genus | Bocconia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Bocconia frutescens exhibits a remarkably wide geographical range that spans across several diverse continents. In the African region, this plant is found throughout the Western Indian Ocean and on the island of Réunion. Its presence extends deep into tropical Asia, specifically covering the Indian Subcontinent, Sri Lanka, and the Malesian region of Jawa. The species also establishes itself in Northern America, specifically within the varied landscapes of Mexico. This distribution includes both the central territories and the coastal areas of the Mexican Gulf.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Bocconia frutescens is a self-supporting plant that typically takes on a shrub-like growth form. This species exhibits significant variability in size, with heights generally ranging from a minimum of 2 meters to a maximum of 6 meters. In many instances, the plant may reach a more substantial stature of at least 5 meters. Such diverse dimensions allow it to adapt effectively to its surrounding environment. Understanding these structural relationships is essential for identifying the plant in the wild.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Bocconia frutescens is traditionally used in infusions to treat cough and various gastrointestinal disorders. Scientific evaluations have demonstrated that aqueous extracts of this plant possess significant antisecretory activity to address digestive issues. Furthermore, the plant exhibits promising anthelmintic effects against the parasite Fasciola hepatica. It also shows anti-leishmanial activity against Leishmania sp., making it a candidate for leishmaniosis treatment. Additionally, extracts of the plant have demonstrated moderate antitrichomonal activity against Trichomonas vaginalis, the agent responsible for trichomoniasis.
Preparations
Bocconia frutescens is prepared as bark and leaf crude extracts to evaluate its antimycobacterial activity. This plant is also processed as crude methanolic extracts for screening antitrichomonal activity against Trichomonas vaginalis. In studies regarding gastrointestinal disorders, Bocconia frutescens is prepared as an aqueous extract to test its antisecretory effects. Research also utilizes various extracts of the species to determine its in vitro anthelmintic efficacy against Fasciola hepatica. Additionally, Bocconia frutescens is prepared as fresh or dried hidroalcoholic extracts to investigate its anti-leishmanial potential.
Parts used
Bocconia frutescens serves as a significant subject in the study of traditional Mexican medicinal plants used to combat tuberculosis. Researchers investigated various parts of this species to determine their effectiveness against Mycobacterium tuberculosis. Specifically, the study examined the antimicrobial properties found within the plant's leaf extracts. Results indicated that methanol and hexane leaf extracts from this plant exhibited a minimal inhibitory concentration of 125 microg/mL. These findings contribute to the ongoing search for alternative drugs to address this serious global health threat.